DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Jain P, Kantarjian H, Patel KP, Gonzalez GN, Luthra R, Kanagal ShamannaR. et al
Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors.
Blood 2016;
127: 1269-75
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.